Trial intelligence / Profile preview

Early vs Late Corticosteroid Withdrawal in Liver Transplant Recipients

NCT02095418Unknown

Sponsor
Samsung Medical Center
Start
Feb 2014
Primary completion
Feb 2018
Countries
1
01

Overview

Randomised, open-label trial of corticosteroids in diabetes mellitus (DM) (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Incidence of New-Onset Diabetes After Transplantation at 1 year. Status: unknown.

02

Drugs

corticosteroids
03

Conditions

diabetes mellitus (DM)

Beyond the preview

Go deeper on NCT02095418.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02095418.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call